Abstract: Provided is a drug sustained-release agent including a carbon material (porous carbon material) which has an inverse opal structure. The drug sustained-release agent includes a porous carbon material which has spherical pores having an average diameter of 1×10-9 to 1×10-5 m and arrayed three-dimensionally and which has a surface area of 3×102 m2/g. Or, the drug sustained-release agent includes a porous carbon material in which pores are arrayed in an arrangement corresponding to a crystal structure on a macroscopic basis. Or, the drug sustained-release agent includes a porous carbon material in which pores are arrayed at a surface thereof in an arrangement corresponding to the (111) plane orientation of a face-centered cubic structure on a macroscopic basis.
| # | Name | Date |
|---|---|---|
| 1 | 1025-delnp-2011-Correspondence-others-(26-05-2011).pdf | 2011-05-26 |
| 2 | 1025-delnp-2011-gpa.pdf | 2011-08-21 |
| 3 | 1025-delnp-2011-form-5.pdf | 2011-08-21 |
| 4 | 1025-delnp-2011-form-3.pdf | 2011-08-21 |
| 5 | 1025-delnp-2011-form-2.pdf | 2011-08-21 |
| 6 | 1025-delnp-2011-form-18.pdf | 2011-08-21 |
| 7 | 1025-delnp-2011-form-1.pdf | 2011-08-21 |
| 8 | 1025-delnp-2011-drawings.pdf | 2011-08-21 |
| 9 | 1025-delnp-2011-description (complete).pdf | 2011-08-21 |
| 10 | 1025-delnp-2011-correspondence-others.pdf | 2011-08-21 |
| 11 | 1025-delnp-2011-claims.pdf | 2011-08-21 |
| 12 | 1025-delnp-2011-abstract.pdf | 2011-08-21 |
| 13 | 1025-delnp-2011-Correspondence Others-(20-04-2012).pdf | 2012-04-20 |
| 14 | 1025-delnp-2011-Form-3-(27-06-2012).pdf | 2012-06-27 |
| 15 | 1025-delnp-2011-Correspondence-Others-(27-06-2012).pdf | 2012-06-27 |
| 16 | 1025-delnp-2011-Form-3-(11-07-2012).pdf | 2012-07-11 |
| 17 | 1025-delnp-2011-Correspondence-Others-(11-07-2012).pdf | 2012-07-11 |
| 18 | 1025-DELNP-2011_EXAMREPORT.pdf | 2016-06-30 |